SCHEMBL2114646

SCHEMBL2114646

O=C(Nc1ccc2nc(NC(=O)c3ccc([N+](=O)[O-])o3)sc2c1)c1ccc([N+](=O)[O-])o1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.88
▸ MEN1 O00255 6/20 0.88
▸ RAB9A P51151 9/20 0.74
▸ NPC1 O15118 8/20 0.74
▸ POLB P06746 3/20 0.74
▸ CASP3 P42574 2/20 0.74
▸ SENP8 Q96LD8 2/20 0.74
▸ SENP7 Q9BQF6 2/20 0.74
▸ SENP6 Q9GZR1 2/20 0.74
▸ TNF P01375 1/20 0.61
▸ CRHBP P24387 1/20 0.61
▸ CRHR2 Q13324 1/20 0.61
▸ NOD2 Q9HC29 1/20 0.61
▸ NOD1 Q9Y239 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ LMNA P02545 4/20 0.58
▸ MAPT P10636 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ THRB P10828 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17856947 0.94 KMT2A (0.92) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL15281360 0.94 MEN1 (1.00) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2116597 0.93 MEN1 (0.77) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2117200 0.92 KMT2A (0.76) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2116574 0.91 MEN1 (0.78) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2115652 0.91 MEN1 (0.75) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2114943 0.91 MEN1 (0.75) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2116594 0.90 MEN1 (0.72) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2117493 0.89 MEN1 (0.80) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2118108 0.89 MEN1 (0.71) KMT2AMEN1RAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095021-A1 SYNTHSIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2012-04-19 — — US claimed
US-9949970-B2 Synthesis of new benzothiazole derivatives as potential anti-tubercular agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-04-24 — — US disclosed
US-9949970-B2 Synthesis of new benzothiazole derivatives as potential anti-tubercular agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-04-24 — — US disclosed
US-20160175303-A1 SYNTHESIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-06-23 — — US disclosed
US-20160175303-A1 SYNTHESIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-06-23 — — US disclosed
US-20160175303-A1 SYNTHESIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-06-23 — — US disclosed
US-9273039-B2 Synthesis of new benzothiazole derivatives as potential anti-tubercular agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-03-01 — — US disclosed
US-9273039-B2 Synthesis of new benzothiazole derivatives as potential anti-tubercular agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-03-01 — — US disclosed
US-9273039-B2 Synthesis of new benzothiazole derivatives as potential anti-tubercular agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-03-01 — — US disclosed
US-20120095021-A1 SYNTHSIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2012-04-19 — — US disclosed
US-20120095021-A1 SYNTHSIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2012-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160175303-A1 SYNTHESIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS TST, TBCA, SDHA KMT2A 3916/4885MEN1 3843/4885RAB9A 2476/4885
US-20120095021-A1 SYNTHSIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS TST, SDHB, SDHA KMT2A 4072/4885MEN1 3854/4885RAB9A 4194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback